## Abstract The __NF2__ gene is a putative tumorβsuppressor gene that, when it is altered in the germline, causes neurofibromatosis type 2, a tumorβsusceptibility disease that mainly predisposes to schwannomas and meningiomas. The recent isolation of the __NF2__ gene on chromosome 22 allows the ide
Frequency and distribution of NF2 mutations in schwannomas
β Scribed by Lee B. Jacoby; Mia MacCollin; Rosemary Barone; Vijaya Ramesh; James F. Gusella
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 832 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
Sporadic and inherited schwannomas were scanned for the nature, frequency, and distribution of mutations in the NF2 locus encoding the merlin tumor suppressor protein on 22q. Of 58 tumors, 47% displayed loss of heterozygosity for NFZ, leaving a total of 89 NF2 alleles t o be examined. Pathogenic alterations were identified in 62 of these alleles, including 36 frameshifts with premature termination, I 4 nonsense mutations, and I 2 changes presumed t o affect splicing. Effects of ten of the latter were confirmed in the NFZ transcript and indicated that activation of cryptic splice sites in coding sequence is another frequent mechanism leading t o truncation of merlin. The mutations were relatively evenly distributed across both the protein 4. I superfamily (exons 1-9) and the a-helical (exons 10-1 5) domains of merlin, but they did not occur at all in exons I 6 and 17, which encode the protein's alternative COOH-termini. The data support the "two-hit'' tumor suppressor model for formation of schwannomas and indicate that loss of merlin function can be achieved by truncation at various locations in the protein.
However, the absence of mutations in exons I 6 and I7 suggests that an inactivating mutation affecting only one of the merlin's alternative termini may not be sufficient t o eliminate tumor suppressor function. Genes Chromosom Cancer I7:45-55 (1996).
π SIMILAR VOLUMES
The frequency and distribution of eight mutations ( R l l lX, IVS4nt-1, Y204C, R243Q, IVS7nt-2, W326X, Y356X, and R413P) in the phenylalanine hydroxylase gene of Orientals in Japan and Korea were examined by allele-specific oligonucleotide hybridization. The mutant alleles comprised 54 and 550/0 of
Schwannomatosis is characterized by the onset of multiple intracranial, spinal, or peripheral schwannomas, without involvement of the vestibular nerve, which is instead pathognomonic of neurofibromatosis type 2 (NF2). Recently, a schwannomatosis family with a germline mutation of the SMARCB1 gene on
## Abstract Schwannomas are benign tumors of cranial, spinal, and other nerve sheaths that develop sporadically or are inherited as part of neurofibromatosis type 2 (NF2). The __NF2__ gene (__SCH__) on chromosome 22 has recently been identified and shown to be inactivated by mutation and allele los
## Abstract Neurofibromatosis 2 (NF2) is a genetic disorder caused by mutational inactivation of the __NF2__ gene and is characterized by bilateral vestibular schwannomas, spinal tumors, and other benign tumors of the nervous system. Previously, we found intragenic __NF2__ mutations in 99 of 188 un
Neurofibromatosiis type 2 (NF2) is a monogenic dominantly inherited disease that predisposes t o the development of tumors of the nervous system, particularly meningiomas and schwannomas. The gene which, when altered, causes NF2, is localized on chromosome 22 and has recently been identified. The NF